Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Journal articles

Murugasu A; Miller J; Proietto A; Millar E, 2003, 'Extragenital mullerian adenosarcoma with sarcomatous overgrowth arising in an endometriotic cyst in the pouch of Douglas', International Journal of Gynecological Cancer, 13, pp. 371 - 375, http://dx.doi.org/10.1046/j.1525-1438.2003.13187.x

Millar EKA; Leong ASY, 2001, 'Significance and assessment of margin status in ductal carcinoma in situ of the breast', Advances in Anatomic Pathology, 8, pp. 338 - 344, http://dx.doi.org/10.1097/00125480-200111000-00004

Millar EKA; Beretov J; Sarris M; Lee CS, 2001, 'Mucinous differentiation in colonic adenocarcinoma is associated with a reduction in tumour-infiltrating lymphocytes', European Journal of Surgical Oncology, 27, pp. 273 - 277, http://dx.doi.org/10.1053/ejso.2000.1094

Millar EKA; Pepperall D; Lee CS; Forbes JF, 2001, 'Re: p53 protein detection in breast epithelium by immunohistochemistry [5]', Breast, 10, pp. 263 - 265, http://dx.doi.org/10.1054/brst.2000.0194

Millar EK; Beretov J; Sarris M; Clarke RA; Kearsley J; Lee CC, 2000, 'Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.', Histopathology, pp. 491 - 496

Millar EKA; Waldron S; Spencer A; Braye S, 1999, 'CD10 positive thyroid marginal zone non-Hodgkin lymphoma', Journal of Clinical Pathology, 52, pp. 849 - 850, http://dx.doi.org/10.1136/jcp.52.11.849

Millar EK; Cappelen-Smith C; Sarris M; Clarke RA; Kearsley J; Lee CC, 1998, 'Prognostic factors in cutaneous malignant melanoma', Cancer Forum, pp. 178 - 180

Millar EKA; Sharma NK; Lessells AM, 1996, 'Ductal (endometrioid) adenocarcinoma of the prostate: A clinicopathological study of 16 cases', Histopathology, 29, pp. 11 - 19, http://dx.doi.org/10.1046/j.1365-2559.1996.d01-483.x

MILLAR EKA; JONES RV; LANG S, 1994, 'PROSTATIC ADENOCARCINOMA METASTATIC TO THE PALATINE TONSIL - A CASE-REPORT', JOURNAL OF LARYNGOLOGY AND OTOLOGY, 108, pp. 178 - 180, http://dx.doi.org/10.1017/S0022215100126234

Millar EKA, 1994, 'Prostatic Adenocarcinoma Metastatic To The Palatine Tonsil: A Case Report', Journal of Laryngology Otology, 108, pp. 178 - 180, http://dx.doi.org/10.1017/S0022215100126234

Conference Papers

Sandarenu P; Chen J; Slapetova I; Browne L; Graham PH; Swarbrick A; Millar EKA; Song Y; Meijering E, 2024, 'Semi-Supervised Variational Autoencoder for Cell Feature Extraction In Multiplexed Immunofluorescence Images', in Proceedings International Symposium on Biomedical Imaging, Institute of Electrical and Electronics Engineers (IEEE), GREECE, Athens, pp. 1 - 5, presented at 2024 IEEE International Symposium on Biomedical Imaging (ISBI), GREECE, Athens, 27 May 2024 - 30 May 2024, http://dx.doi.org/10.1109/ISBI56570.2024.10635107

Rahaman MM; Millar EKA; Meijering E, 2024, 'Histopathology Image Classification Using Supervised Contrastive Deep Learning', in Proceedings International Symposium on Biomedical Imaging, http://dx.doi.org/10.1109/ISBI56570.2024.10635260

Mondol RK; Millar EKA; Sowmya A; Meijering E, 2024, 'MM-Survnet: Deep Learning-Based Survival Risk Stratification in Breast Cancer Through Multimodal Data Fusion', in Proceedings International Symposium on Biomedical Imaging, http://dx.doi.org/10.1109/ISBI56570.2024.10635810

Casson A; Liu S; Godrich RA; Aghdam H; Lee D; Malfroid K; Rothrock B; Kanan C; Retamero J; Hanna M; Millar E; Klimstra D; Fuchs T, 2023, 'Joint Breast Neoplasm Detection and Subtyping using Multi-Resolution Network Trained on Large-Scale H&E Whole Slide Images with Weak Labels', in Proceedings of Machine Learning Research, pp. 18 - 38

Wang J; Browne L; Slapetova I; Shang F; Lee K; Lynch J; Beretov J; Whan R; Graham P; Millar EK, 2021, 'Multiplexed immunofluorescence identifies stromal CD68+PD-L1+ macrophages as a predictor of outcome in triple negative breast cancer', in Pathology, Elsevier, pp. s38, http://dx.doi.org/10.1016/j.pathol.2021.06.069

Pang J-M; Castles B; Byrne DJ; Button P; Lakhani S; Sivasubramaniam V; Cooper W; Armes J; Millar E; Raymond W; Roberts-Thomson S; Kumar B; Burr ML; Selinger C; Harvey K; Chan C; Beith J; O'Toole SA; Fox SB, 2020, 'SP142 immunohistochemistry (IHC) PD-L1 inter- and intra-pathologist agreement in triple negative breast carcinoma (TNBC)', in Annals of Oncology, Elsevier, pp. s361, http://dx.doi.org/10.1016/j.annonc.2020.08.399

Paththinige N; Blake S; Murrell D; Millar E, 2019, 'Secondary cutaneous plasmacytoma: A bad prognostic marker of multiple myeloma', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 71 - 71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000467967200198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Foy K; Walker P; Millar E; Palastre B, 2017, 'Improving analgesia prescribing confidence in foundation doctors: simple steps work!', in ANAESTHESIA, WILEY, ENGLAND, London, pp. 20 - 20, presented at Winter Scientific Meeting (WSM) London of the Association-of-Anaesthetists-of-Great-Britain-and-Ireland (AAGBI), ENGLAND, London, 11 January 2017 - 13 January 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398061900023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rahbari RM; Xu H; Yan M; Patra J; Natrajan R; Yan Y; Swagemakers S; Tomaszewski J; Verschoor S; Miller EK; Van der Spek P; Reis-Filho J; Ramsay R; O'Toole S; McNeil C; Sutherland R; McKay M; Fox S, 2014, 'Enhanced RAD21 Cohesin Expression Confers Poor Prognosis and Resistance to Chemotherapy in High Grade Luminal, Basal, and HER 2 Breast Cancers', in International Journal of Radiation Oncology • Biology • Physics, Elsevier, pp. s812, http://dx.doi.org/10.1016/j.ijrobp.2014.05.2343

Pajic M; Graham PH; Millar EKA; O'Toole SA; Molloy TJ, 2013, 'MicroRNA-regulated pathways of radiotherapy sensitivity and resistance in breast cancer', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S232 - S232, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843601304&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Molloy T; Pajic M; Holzhauser S; Graham P; Millar EKA; Sutherland RL, 2012, 'Identifying Putative MiRNAs Mediators of Radiotherapy Resistance in Breast Cancer', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SPAIN, Barcelona, pp. S270 - S270, presented at 22nd Biennial Congress of the European-Association-for-Cancer-Research, SPAIN, Barcelona, 07 July 2012 - 10 July 2012, http://dx.doi.org/10.1016/S0959-8049(12)71723-9

Canney M; Liu E; Vonthethoff L; Millar E; Weatherall C; Ong S, 2010, 'NEPHROTIC SYNDROME SECONDARY TO TREPONEMA PALLIDUM', in NEPHROLOGY, WILEY-BLACKWELL, pp. 53 - 53, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Graham P; Millar E; Browne L; Capp A; Fox C; Delaney G; Kearsley J; Nasser E; Papadatos G, 2010, 'RANDOMIZED TRIAL SHOWS REDUCED WHOLE BREAST DOSE REVERSES BENEFIT OF LUMPECTOMY RADIOTHERAPY BOOST', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S145 - S145, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000433351601083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Toole S; Swarbrick A; Millar E; McLeod D; McNeil C; Qiu M; Lopez-Knowles E; Caldon E; Oakes S; Ormandy C; Morey A; Musgrove E; Henshall S; Sutherland R, 2009, 'Aberrent hedgehog signaling is an early event in breast cancer development.', in Cancer Research, American Association for Cancer Research (AACR), pp. 24, http://dx.doi.org/10.1158/0008-5472.sabcs-24

O'Toole S; Swarbrick A; Millar E; McLeod D; McNeil C; Qiu MR; Lopez-Knowles E; Caldon E; Oakes S; Ormandy C; Morey A; Musgrove E; Henshall S; Sutherland R, 2008, 'Aberrent hedgehog signaling is an early event in breast cancer development', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, TX, San Antonio, pp. 70S - 70S, presented at 31st Annual San Antonio Breast Cancer Symposium, TX, San Antonio, 10 December 2008 - 14 December 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000262583200031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Hepburn K; Millar E; Kelly J; Katz I, 2018, 'ANTIBODY NEGATIVE ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE', in NEPHROLOGY, WILEY, Vol. 23, pp. 79 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pang J-M; Chand A; Knower K; Takano E; Byrne D; Sprenkeler E; Molania R; Millar E; Lee S; O'Toole S; Clyne C; Dobrovic A; Fox S, 2015, 'Abstract 2962: LRH-1 expression in breast cancer tissue and its association with phenotype and DNA methylation', in Cancer Research, American Association for Cancer Research (AACR), Vol. 75, pp. 2962 - 2962, http://dx.doi.org/10.1158/1538-7445.am2015-2962

Gallego-Ortega D; Ledger A; Roden D; Cho C; Allerdice SL; Lee HJ; Valdes-Mora F; Lee B; Kaplan W; Salomon R; Piggin C; Rabinovich B; Millar E; Chtanova T; Swarbrick A; Clark S; Ormandy C, 2015, 'The ETS transcription factor ELF5 drives metastasis via angiogenesis and recruitment of Gr-1+ CD11b+ myeloid derived suppressor cells in luminal breast cancer', in Clinical and Experimental Metastasis, Springer Verlag (Germany), Vol. 32, pp. 203 - 203, presented at MRS 15th International biennial congress of the metastasis research society

Nair R; Teo WS; Ye S; McFarland A; Harvey K; Roden D; Junankar S; Baker L; Yang J; Fluke N; Millar E; Mellick A; Naylor M; Ormandy C; Lakhani S; O'Toole S; Swarbrick A, 2015, 'The Inhibitor of Differentiation proteins mediate tumour-initiating properties and metastasis in breast cancer', in CLINICAL & EXPERIMENTAL METASTASIS, SPRINGER, Vol. 32, pp. 224 - 224, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351601900129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Graham PH; Browne L; Capp A; Delaney G; Fox C; Millar EK; Nasser E; Papadatos G, 2015, 'Predictors of responses and sexual function for women in the St George breast boost randomized trial (StGBBT)', in The Breast, Elsevier, Vol. 24, pp. 304, http://dx.doi.org/10.1016/j.breast.2015.02.011

Millar EKA; Coates AS; O'Toole S; Selinger C; Musgrove EA; Yan M; Viale G; Regan MM; Price KN; Sun Z; Castiglione MM; Colleoni M; Gelber RD; Goldhirsch A; Sutherland RL, 2012, 'Intrinsic subtype and its clinical significance in early node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 30, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009800179&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Toole S; Machalek D; Shearer R; Millar E; Nair R; Martelotto L; McLeod D; Cooper C; Ru Qiu M; Sutherland R; Watkins D; Swarbrick A, 2010, 'Abstract S6-8: Hedgehog Ligand Overexpression Predicts Poor Outcome in Breast Cancer and Is a Potential Therapeutic Target for Metastatic Disease', in Cancer Research, American Association for Cancer Research (AACR), Vol. 70, pp. s6-8-s6-8, http://dx.doi.org/10.1158/0008-5472.sabcs10-s6-8

Lopez-Knowles E; O'Toole SA; McNeil CM; Millar EKA; Qiu MR; Crea P; Daly RJ; Musgrove EA; Sutherland RL, 2009, 'PI3K Pathway Activation in Breast Cancer Is Associated with the Basal-Like Phenotype and Cancer-Specific Mortality', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, TX, San Antonio, Vol. 69, pp. 632S - 632S, presented at 32nd Annual San Antonio Breast Cancer Symposium, TX, San Antonio, 09 December 2009 - 13 December 2009

Preprints

Mondol RK; Millar EKA; Graham PH; Browne L; Sowmya A; Meijering E, 2025, GRAPHITE: Graph-Based Interpretable Tissue Examination for Enhanced Explainability in Breast Cancer Histopathology, http://dx.doi.org/10.48550/arxiv.2501.04206

Rahaman MM; Millar EKA; Meijering E, 2025, Leveraging Vision-Language Embeddings for Zero-Shot Learning in Histopathology Images, http://dx.doi.org/10.48550/arxiv.2503.10731

Chen J; Zhang H; Ruan T; Wu S; Slapetova I; Millar E; Graham P; Lynch J; Browne L; Lim E; Swarbrick A, 2025, Stromal cell subsets modulate T-cell infiltration in early breast cancer, http://dx.doi.org/10.1101/2025.10.20.683407

Sandarenu P; Chen J; Slapetova I; Browne L; Graham PH; Swarbrick A; Millar EKA; Song Y; Meijering E, 2024, Semi-supervised variational autoencoder for cell feature extraction in multiplexed immunofluorescence images, http://dx.doi.org/10.48550/arxiv.2406.15727

Mondol RK; Millar EKA; Sowmya A; Meijering E, 2024, BioFusionNet: Deep Learning-Based Survival Risk Stratification in ER+ Breast Cancer Through Multifeature and Multimodal Data Fusion, http://dx.doi.org/10.48550/arxiv.2402.10717

Mondol RK; Millar EKA; Sowmya A; Meijering E, 2024, MM-SurvNet: Deep Learning-Based Survival Risk Stratification in Breast Cancer Through Multimodal Data Fusion, http://dx.doi.org/10.48550/arxiv.2402.11788

Mondol RK; Millar EKA; Graham PH; Browne L; Sowmya A; Meijering E, 2023, hist2RNA: An efficient deep learning architecture to predict gene expression from breast cancer histopathology images, http://dx.doi.org/10.48550/arxiv.2304.04507

Rahaman MM; Millar EKA; Meijering E, 2023, Breast Cancer Histopathology Image based Gene Expression Prediction using Spatial Transcriptomics data and Deep Learning, http://dx.doi.org/10.48550/arxiv.2303.09987

Wu S; Roden D; Al-Eryani G; Bartonicek N; Harvey K; Cazet A; Chan C-L; Junankar S; Hui M; Millar E; Beretov J; Horvath L; Joshua A; Stricker P; Wilmott J; Quek C; Long G; Scolyer R; Yeung B; Segara D; Mak C; Warrier S; Powell J; O'Toole S; Lim E; Swarbrick A, 2020, Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis, http://dx.doi.org/10.1101/2020.06.04.135277

Latham SL; O’Donnell YE; Girgis-Cook O; Clearwater MS; Bryce NS; Mok ET; Lynn SA; Ni J; Alfred S; Leong H; Quek L-E; Murphy KJ; Pantarelli C; Dragutinovic I; Naeini MM; Thiel C; Cadell A; Phimmachanh M; Sharma R; Millar E; Han JZ; Hastings JF; Köhler M; Brummer T; Young A; O’Toole S; Oakes SR; Hardeman E; Lock J; Kolch W; Taft MH; Nobis M; Goldstein L; Timpson P; Parker BL; Holst J; Gunning PW; Cox TR; Morris JC; Croucher DR, A selective inhibitor of oncogenic JNK signalling perturbs metastatic outgrowth of triple-negative breast cancer through metabolic blockade, http://dx.doi.org/10.1101/2025.04.16.649243

Rahaman MM; Millar EKA; Meijering E, Breast cancer histopathology image-based gene expression prediction using spatial transcriptomics data and deep learning, http://dx.doi.org/10.21203/rs.3.rs-2983276/v1

Teo WS; Holliday H; Karthikeyan N; Cazet AS; Roden DL; Harvey K; Konrad CV; Murali R; Varghese BA; Archana PT; Chan C-L; McFarland A; Junankar S; Ye S; Yang J; Nikolic I; Shah JS; Baker LA; Millar EKA; Naylor MJ; Ormandy CJ; Lakhani SR; Kaplan W; Mellick AS; O’Toole SA; Swarbrick A; Nair R, Id proteins promote a cancer stem cell phenotype in triple negative breast cancer via negative regulation of Robo1, http://dx.doi.org/10.1101/497313

Alexandrou S; Lee CS; Fernandez KJ; Wiharja CE; Eshraghi L; Reeves J; Reed DA; Portman N; Phan Z; Milioli HH; Nikolic I; Cadell AL; Croucher DR; Simpson KJ; Lim E; Hickey TE; Millar EKA; Alves CL; Ditzel HJ; Caldon CE, JNK pathway suppression drives resistance to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer, http://dx.doi.org/10.1101/2025.01.08.631992


Back to profile page